Entera Bio annual gross margin
2019
2020
2021
2022
2024
2025
Entera Bio's gross margin was 0.00% for fiscal 2025.
View full Entera Bio company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 0.00% | −4.97 pp |
| 2024 | 2024-12-31 | 4.97% | — |
| 2022 | 2022-12-31 | 24.63% | −10.05 pp |
| 2021 | 2021-12-31 | 34.68% | +16.87 pp |
| 2020 | 2020-12-31 | 17.81% | +6.79 pp |
| 2019 | 2019-12-31 | 11.02% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | 0.00% | — |
| Q4 2024 | 2024-12-31 | 0.00% | — |
| Q3 2024 | 2024-09-30 | 0.00% | — |
| Q2 2024 | 2024-06-30 | 15.79% | — |
| Q4 2022 | 2022-12-31 | 42.86% | +25.28 pp |
| Q3 2022 | 2022-09-30 | 25.00% | −28.57 pp |
| Q2 2022 | 2022-06-30 | 25.00% | +15.83 pp |
| Q1 2022 | 2022-03-31 | 20.59% | −32.91 pp |
| Q4 2021 | 2021-12-31 | 17.58% | — |
| Q3 2021 | 2021-09-30 | 53.57% | — |
| Q2 2021 | 2021-06-30 | 9.17% | −31.21 pp |
| Q1 2021 | 2021-03-31 | 53.50% | — |
| Q2 2020 | 2020-06-30 | 40.38% | +24.17 pp |
| Q2 2019 | 2019-06-30 | 16.22% | — |
Over the last five fiscal years, Entera Bio's gross margin decreased from 17.81% to 0.00%, a change of −17.81 percentage points. The latest reported quarter, Q1 2025, shows 0.00%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗